(800)525-7111 Free Consultation

Zantac Investigation Launched by Department of Justice

Riddle Brantley LLP   |  August 6, 2020   |  

The Department of Justice has opened an investigation into Zantac manufacturers Sanofi and GlaxoSmithKline (GSK) in the wake of Food & Drug Administration (FDA) findings that the popular heartburn medication contains cancer-causing NDMA. The Justice Department’s Zantac investigation is specifically focused on whether Sanofi and/or GSK violated the False Claims Act in not alerting consumers that Zantac may cause cancer.

Zantac Investigation Launched by Department of Justice - Riddle & BrantleyThe Justice Department’s Zantac investigation was disclosed in Sanofi and GSK filings with the Securities and Exchange Commission (SEC). The companies also disclosed a lawsuit filed by the Attorney General of the State of New Mexico, which alleges that the Zantac manufacturers violated the state’s unfair practices act and engaged in false advertising, public nuisance, and negligence.

In response to the Justice Department’s investigation into Zantac, a spokeswoman for Sanofi said that the company stands by “long-standing science that supports the safety of Zantac OTC products, which have been used by consumers for over two decades.” GSK declined to comment but said that the company is cooperating with the investigation.

The FDA issued an emergency order removing Zantac and its generic equivalent, ranitidine, from the U.S. market in April 2020, citing “unacceptable” levels of cancer-causing NDMA contamination.

Both the World Health Organization (WHO) and Environmental Protection Agency (EPA) classify NDMA as a probable human carcinogen, meaning it can cause cancer.

Will the Zantac Investigation Strengthen Cancer Lawsuits?

Zantac Manufacturer Lawsuits - Riddle & BrantleyAlongside the Zantac investigation by the Justice Department, Zantac and generic ranitidine manufacturers like Sanofi and GSK face increasing Zantac lawsuits, alleging that these companies failed to warn consumers about NDMA contamination in Zantac. Thousands of U.S. residents have alleged that NDMA-contaminated Zantac caused their cancer and are seeking significant damages.

Legal analysts anticipate that potential Zantac claims may cost these drugmakers billions of dollars. In disclosing the Justice Department investigation and pending Zantac lawsuits, Sanofi and GSK said they could not estimate the potential cost of the legal action.

Have you been diagnosed with cancer after taking Zantac?

If you or a loved one have taken brand-name Zantac and been diagnosed with a qualifying cancer, you may be entitled to significant financial compensation. Our firm is actively investigating these claims and we would love to help you seek justice if we can.

For a FREE, no-obligation consultation with an experienced Zantac cancer lawyer, please call 1-800-525-7111 or complete the fast and easy form below.

There is no obligation and you won’t pay any upfront costs or attorney fees unless we win your case and you receive compensation for your Zantac claim.

Please call 1-800-525-7111 today for a free, no-obligation consultation concerning your Zantac cancer claim.

IMPORTANT: A federal judge recently ruled against lawsuits concerning generic Zantac. At this point, we can only accept cases concerning use of brand-name Zantac OR “mixed” use of brand-name Zantac and generic equivalents.

NDMA in Zantac has been associated with at least 20 different types of cancer. The following cancers may qualify you for a Zantac cancer lawsuit:

If you’ve been diagnosed with cancer after taking brand-name Zantac, don’t wait — now is the time to have your claim investigated.

PLEASE NOTE: At this time, the federal MDL has limited the Zantac claims we can accept to bladder, esophageal, stomach, liver, and pancreatic cancers only. We understand that other cancers may be linked, but we are unfortunately unable to assist with these claims at this time due to evidence and recent court rulings.

For a FREE, no-obligation consultation regarding your potential Zantac lawsuit, please call 1-800-525-7111 today.

Zantac Cancer Lawyers - Riddle & Brantley (1)Our Zantac cancer lawsuit attorneys will review your claim, advise you on your best legal options, and if you decide to hire us, fight tirelessly for your right to justice and compensation.

We have been fighting to hold potentially negligent drug manufacturers accountable for more than three decades and would love to help however we can. Our dangerous drug attorneys have more than 220+ years of combined legal experience and are led by Gene Riddle, an award-winning injury lawyer who has been recognized by such prestigious organizations as Multi-Million Dollar Advocates Forum, The National Trial Lawyers Top 100, The National Association of Distinguished Counsel, and Super Lawyers (see disclaimer below).

If you’re considering Riddle & Brantley for representing you in your Zantac cancer claim, we invite you to consider what our clients are saying about their experience working with our attorneys and staff. We also welcome you to review our record of significant settlements and judgments (see disclaimer below).

For a FREE, no-obligation consultation with an experienced Zantac cancer lawyer, please call 1-800-525-7111 or complete the fast and easy form below.

The consultation is free and there are no attorney fees unless we win your case and you receive compensation.

Justice Counts for those diagnosed with cancer potentially due to NDMA contamination in Zantac.

Call 1-800-525-7111 today and let’s review your case. We are ready to listen.


*** Disclaimer: An attorney must meet certain requirements to join these organizations or receive these awards. For more information on Membership Criteria for Million Dollar Advocates Forum, Multi-Million Dollar Advocates Forum, Super Lawyers, The National Trial Lawyers Top 100, The National Trial Lawyers Top 40 Under 40, The National Association of Distinguished Counsel, AV Preeminent by Martindale-Hubbell, the Litigator Award, and other memberships, awards, and accolades, please visit our Membership Criteria page. These awards and memberships should not be construed as a promise or guarantee of a similar result. Each case is different and must be evaluated separately.